Literature DB >> 31784790

Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores.

Cameron B Speyer1, Daniel Li1, Hongshu Guan1, Kazuki Yoshida1, Emma Stevens1, April M Jorge2, Brendan M Everett1, Candace H Feldman1, Karen H Costenbader3.   

Abstract

Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative databases where severity may confound or mediate associations with outcomes. Garris et al. developed an administrative claims-based algorithm employing claims over a 1-year period to classify SLE severity as mild, moderate or severe. We sought to compare this administrative algorithm to a measure of SLE activity, the SLE Disease Activity Index-2000 (SLEDAI-2K) score at clinical visits. We identified 100 SLE patients followed in the Brigham and Women's Hospital (BWH) Lupus Center (in 2008-2010) with SLEDAI-2K scores at each visit over a 1-year period per person. We obtained data for the Garris algorithm for the same year per subject. We compared Garris SLE severity to the highest SLEDAI-2K in that year, with SLEDAI-2K categories of mild < 3, moderate 3-6, and severe > 6. We compared classification using weighted kappa statistics, and positive and negative predictive values (PPV, NPV). We also assessed the binary comparison of mild vs. moderate/severe. We calculated sensitivity, specificity, and McNemar's test. We analyzed 377 SLEDAI-2K assessments (mean 3.8 [SD 2.6] per subject/year). For classifying moderate/severe vs. mild SLE severity, the sensitivity was 85.7%, specificity 67.6%, PPV 81.8% and NPV 73.5%. The Garris algorithm for classifying SLE severity in administrative datasets had moderate agreement for classification of mild vs. moderate/severe SLE activity assessed by SLEDAI-2K assessments in an academic lupus center. It may be a useful tool for classifying SLE severity in administrative database studies.

Entities:  

Keywords:  Administrative; Algorithm; Claims data; Severity; Systemic lupus erythematosus

Year:  2019        PMID: 31784790      PMCID: PMC6960319          DOI: 10.1007/s00296-019-04477-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

1.  BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus.

Authors:  D A Isenberg; A Rahman; E Allen; V Farewell; M Akil; I N Bruce; D D'Cruz; B Griffiths; M Khamashta; P Maddison; N McHugh; M Snaith; L S Teh; C S Yee; A Zoma; C Gordon
Journal:  Rheumatology (Oxford)       Date:  2005-04-06       Impact factor: 7.580

2.  Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1968-10       Impact factor: 17.737

3.  Validity and reliability of lupus activity measures in the routine clinic setting.

Authors:  M Petri; D Hellmann; M Hochberg
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

4.  Calculating the benefits of a Research Patient Data Repository.

Authors:  Ruth Nalichowski; Diane Keogh; Henry C Chueh; Shawn N Murphy
Journal:  AMIA Annu Symp Proc       Date:  2006

5.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

6.  Defining Low Disease Activity in Systemic Lupus Erythematosus.

Authors:  Ari Polachek; Dafna D Gladman; Jiandong Su; Murray B Urowitz
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-07       Impact factor: 4.794

7.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

8.  Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.

Authors:  Cindy Garris; Priti Jhingran; Damon Bass; Nicole M Engel-Nitz; Aylin Riedel; Greg Dennis
Journal:  J Med Econ       Date:  2013-03-11       Impact factor: 2.448

9.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.

Authors:  M H Liang; S A Socher; M G Larson; P H Schur
Journal:  Arthritis Rheum       Date:  1989-09

10.  Interrater reliability: the kappa statistic.

Authors:  Mary L McHugh
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  10 in total
  6 in total

1.  Factors Associated with Survey Non-Response in a Cross-Sectional Survey of Persons with an Axial Spondyloarthritis or Osteoarthritis Claims Diagnosis.

Authors:  Johanna Callhoff; Hannes Jacobs; Katinka Albrecht; Joachim Saam; Angela Zink; Falk Hoffmann
Journal:  Int J Environ Res Public Health       Date:  2020-12-09       Impact factor: 3.390

2.  The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization.

Authors:  Andreas Schwarting; Heiko Friedel; Elena Garal-Pantaler; Marc Pignot; Xia Wang; Henk Nab; Barnabas Desta; Edward R Hammond
Journal:  Rheumatol Ther       Date:  2021-02-05

3.  Validation of a machine learning approach to estimate Clinical Disease Activity Index Scores for rheumatoid arthritis.

Authors:  Alison K Spencer; Jigar Bandaria; Michelle B Leavy; Benjamin Gliklich; Zhaohui Su; Gary Curhan; Costas Boussios
Journal:  RMD Open       Date:  2021-11

4.  Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis.

Authors:  Julia Langham; Volkan Barut; Mihail Samnaliev; Sue Langham; Sharada Weir; Xia Wang; Barnabas Desta; Edward Hammond
Journal:  Rheumatol Adv Pract       Date:  2021-08-27

5.  Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis.

Authors:  Mihail Samnaliev; Volkan Barut; Sharada Weir; Julia Langham; Sue Langham; Xia Wang; Barnabas Desta; Edward Hammond
Journal:  Rheumatol Adv Pract       Date:  2021-09-16

6.  Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus.

Authors:  Sebastian Bruera; Xiudong Lei; Brandon Blau; Hui Zhao; Anita Deswal; Jinoos Yazdany; Sharon H Giordano; Maria E Suarez-Almazor
Journal:  ACR Open Rheumatol       Date:  2022-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.